Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis Journal Article


Authors: Tricarico, R.; Cortellino, S.; Riccio, A.; Jagmohan-Changur, S.; Van der Klift, H.; Wijnen, J.; Turner, D.; Ventura, A.; Rovella, V.; Percesepe, A.; Lucci-Cordisco, E.; Radice, P.; Bertario, L.; Pedroni, M.; de Leon, M. P.; Mancuso, P.; Devarajan, K.; Cai, K. Q.; Klein-Szanto, A. J. P.; Neri, G.; Möller, P.; Viel, A.; Genuardi, M.; Fodde, R.; Bellacosa, A.
Article Title: Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis
Abstract: The DNA glycosylase gene MBD4 safeguards genomic stability at CpG sites and is frequently mutated at coding poly-A tracks in mismatch repair (MMR)-defective colorectal tumors (CRC). Mbd4 biallelic inactivation in mice provided conflicting results as to its role in tumorigenesis. Thus, it is unclear whether MBD4 alterations are only secondary to MMR defects without functional consequences or can contribute to the mutator phenotype. We investigated MBD4 variants in a large series of hereditary/familial and sporadic CRC cases. Whereas MBD4 frameshifts were only detected in tumors, missense variants were found in both normal and tumor DNA. In CRC with double-MBD4/MMR and single-MBD4 variants, transition mutation frequency was increased, indicating that MBD4 defects may affect the mutational landscape independently of MMR defect. Mbd4-deficient mice showed reduced survival when combined with Mlh1-/- genotype. Taken together, these data suggest that MBD4 inactivation may contribute to tumorigenesis, acting as a modifier of MMR-deficient cancer phenotype.
Keywords: immunohistochemistry; unclassified drug; gene mutation; gene sequence; sequence analysis; frameshift mutation; missense mutation; histopathology; nonhuman; colorectal cancer; mouse; phenotype; allele; gene; protein; genetic variability; carcinogenesis; cpg island; genomic instability; colorectal tumor; mismatch repair; genetic code; hnpcc; mutations; dna glycosyltransferase; human; article; mbd4 gene; mbd4/med1; mbd4 protein
Journal Title: Oncotarget
Volume: 6
Issue: 40
ISSN: 1949-2553
Publisher: Impact Journals  
Date Published: 2015-12-15
Start Page: 42892
End Page: 42904
Language: English
DOI: 10.18632/oncotarget.5740
PROVIDER: scopus
PUBMED: 26503472
PMCID: PMC4767479
DOI/URL:
Notes: Article -- Export Date: 3 February 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrea Ventura
    56 Ventura